Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus
NCT05261529 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2022-12-20
Summary
In addition to the different pharmacological therapies available for the treatment of Systemic Lupus Erythematosus (SLE) as well as for its numerous associated complications (cutaneous, articular, hematological, neuropsychiatric, renal...), it has recently been proposed that 'health-related lifestyles' could have a determining role in balancing numerous organic processes at all levels. In line with this, the benefits of following a healthy dietary pattern such as the Mediterranean Diet and, specifically, the intake of Extra Virgin Olive Oil (EVOO) as well as the realization of regular physical exercise (PE) have been examined in numerous chronic non-communicable diseases such as obesity or cancer. However, in patients with autoimmune diseases, such as SLE, the possible effects of this synergy has not been investigated to date. Having demonstrated both the protective effect of a healthy dietary pattern and that of regular PE on the progression and risks associated with SLE in cross-sectional studies, non-intervention research has been developed that combines both strategies simultaneously, with nutritional supplementation or PE occurring independently. It is hypothesized that supplementation with EVOO in these patients together with PE will produce superior benefits compared to EVOO supplementation alone, showing changes in the phenotype of SLE and other parameters such as levels of chronicity/gravity, biomarkers (oxidative stress, immunological, inflammation), cardiovascular status and body composition.
Conditions
- Lupus Erythematosus, Systemic
Interventions
- DIETARY_SUPPLEMENT
-
Extra Virgin Olive Oil (EVOO)
Daily intake of 40ml EVOO added to the normal intake of EVOO of the participants.
- BEHAVIORAL
-
Physical Exercise Program
Besides the EVOO supplementation in the same conditions as the 'Intervention 1 Group', participants will add the follow-up of a Multimodal Physical Exercise (MFE) program during the remaining 12 weeks of intervention, 3 days per week, online and face-to-face group sessions on non-consecutive days. Continuous and intervalic cardiovascular exercise at moderate-intense intensity, controlled by the HR in reserve, with a duration of 15-45 minutes, also including sympathetic modulation exercises (stretching, breathing and meditation) and methods to promote recovery, with a duration of 10-30 minutes.
Sponsors & Collaborators
-
Consejería de Economía, Innovación y Ciencia. Proyectos de I+D+I en el marco operativo Feder Andalucía 2014-2020
collaborator UNKNOWN -
Universidad de Granada
lead OTHER
Principal Investigators
-
María Correa Rodríguez, Professor · Universidad de Granada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-03
- Primary Completion
- 2022-12-30
- Completion
- 2023-06-30
Countries
- Spain
Study Locations
More Related Trials
-
Exercise and Systemic Lupus Erythematosus
NCT01515163 ·Status: UNKNOWN ·Phase: NA
-
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
NCT02338999 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
NCT03537638 ·Status: COMPLETED ·Phase: NA
-
Lupus Intervention for Fatigue Trial
NCT02653287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
NCT06032923 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
NCT06166199 ·Status: RECRUITING ·Phase: NA
-
Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG)
NCT05090189 ·Status: UNKNOWN ·Phase: NA
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Systemic Lupus Erythematosus Exercise Program
NCT03942718 ·Status: COMPLETED ·Phase: NA
-
Physical Activity in Patients With Systemic Lupus Erythematosus
NCT00985803 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
NCT00006134 ·Status: COMPLETED
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Ultraviolet Light Therapy for Systemic Lupus Erythematosus
NCT00004375 ·Status: UNKNOWN ·Phase: PHASE2
-
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
NCT02655640 ·Status: COMPLETED
-
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
NCT01322308 ·Status: COMPLETED ·Phase: PHASE4
-
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
NCT05379725 ·Status: TERMINATED ·Phase: NA
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Validation of Patient E-tool to Measure Systemic Lupus Activity
NCT05763225 ·Status: COMPLETED
-
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
NCT02265744 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Lipids in Immune Cell Function in SLE Patients
NCT04361734 ·Status: UNKNOWN
-
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184 ·Status: COMPLETED ·Phase: NA
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156 ·Status: COMPLETED ·Phase: NA